This inventor holds 1 USPTO granted patent. Top assignee: University of Utah Research Foundation. Active years: 2007.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2007
Title: The Innovative Mind of Jae-Woon Nah: A Pioneer in Gene Delivery Technology
Introduction
Jae-Woon Nah, an innovative inventor hailing from Suncheon, South Korea, has made significant strides in the realm of gene delivery systems. With a keen focus on enhancing medical treatment options, Nah holds a patent that addresses critical challenges in targeted gene therapy.
Latest Patents
Jae-Woon Nah's notable patent is centered around a “Carrier system for specific artery wall gene delivery.” This invention involves the utilization of an artery wall binding peptide (AWBP), derived from the artery wall cell-binding domain of apolipoprotein B-100. It is expertly conjugated to a cationic backbone that forms a complex with nucleic acids, optimizing gene transfer to artery wall cells. The patented composition, which incorporates a cationic backbone such as poly(ethylene glycol)-grafted-poly(L-lysine) (PEG-g-PLL), demonstrates promising capabilities in enhancing the efficacy of gene therapies aimed at vascular diseases.
Career Highlights
Jae-Woon Nah is affiliated with the University of Utah Research Foundation, where he contributes to groundbreaking research in biotechnology and gene delivery systems. His work has garnered attention for its potential to significantly improve outcomes for patients requiring targeted therapeutic interventions.
Collaborations
Throughout his career, Nah has collaborated with notable researchers Lei Yu and Sung Wan Kim. These partnerships have fostered a collaborative environment that promotes innovation and advances the field of gene therapy, illustrating the benefits of teamwork in scientific research.
Conclusion
Jae-Woon Nah's contributions to the field of gene delivery technology reflect his commitment to innovation and improving patient care. His patent not only showcases his expertise but also highlights the critical intersection of research and application in medicine. As he continues his work at the University of Utah Research Foundation, his future endeavors hold the promise of further advancements in therapeutic solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile